Related Experiment Video
Updated: Jun 28, 2025

03:50
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
Published on: August 2, 2024
1.1K
[Low-intensity extracorporeal shock wave therapy for erectile dysfunction: An update]
Meng-Fei Ma1, Shi-Hao Wang2, Song Xu1,2,3
1Jinling School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210002, China.
Zhonghua Nan Ke Xue = National Journal of Andrology
|April 10, 2024
Summary
Low-intensity extracorporeal shock wave therapy (Li-ESWT) shows promise for treating erectile dysfunction (ED). This therapy may enhance erectile function by promoting blood vessel growth and healing damaged penile tissue.
Area of Science:
- Urology
- Regenerative Medicine
Background:
- Erectile dysfunction (ED) significantly impacts men's quality of life.
- Vascular ED is a common form, often linked to insufficient blood flow.
- Current treatments have limitations, necessitating novel therapeutic approaches.
Approach:
- Review of pathophysiological mechanisms of ED.
- Analysis of clinical applications of low-intensity extracorporeal shock wave therapy (Li-ESWT).
- Evaluation of Li-ESWT's efficacy and safety in treating vascular ED.
Key Points:
- Li-ESWT may improve erectile function by inducing angiogenesis (new blood vessel formation).
- The therapy helps reverse pathological changes in erectile tissue.
- Li-ESWT is considered a safe, effective, and tolerable treatment option for vascular ED.
Conclusions:
- Li-ESWT presents a promising therapeutic strategy for men with erectile dysfunction.
- Understanding the mechanism of action is crucial for optimizing treatment outcomes.
- Further research can solidify Li-ESWT's role in managing vascular ED.
Related Concept Videos
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
150
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
150

